Evidence map›Paper›PMID 27994221›Full record

ArticleMolecular psychiatry2018

Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4.

C Zussy, X Gómez-Santacana, X Rovira, D De Bundel, S Ferrazzo, D Bosch, D Asede, F Malhaire, F Acher, J Giraldo and 6 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Light-Activated Agonist-Potentiator of GABAJournal of the American Chemical Society · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. A Diet Enriched withInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. Article
  12. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. A nanobody activating metabotropic glutamate receptor 4 discriminates between homo- and heterodimers.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  18. Article
  19. Review
  20. ACS chemical neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

C ZussyInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
X Gómez-SantacanaMCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
X RoviraInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
D De BundelInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
S FerrazzoDepartment of Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
D BoschHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
D AsedeHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
F MalhaireInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
F AcherLaboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, CNRS UMR8601, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
J GiraldoLaboratory of Molecular Neuropharmacology and Bioinformatics, Institut de Neurociències and Unitat de Bioestadística, Universitat Autònoma de Barcelona, Bellaterra, Spain.
E ValjentInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
I EhrlichHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
F FerragutiDepartment of Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
J-P PinInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
A LlebariaMCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
C GoudetInstitut de Génomique Fonctionnelle, CNRS, UMR-5203, Université de Montpellier, Montpellier, France.
Université de Montpellier · FRInstitut de Génomique Fonctionnelle · FRUniversity of Tübingen · DEInnsbruck Medical University · ATInstitute of Advanced Chemistry of Catalonia · ESCentre National de la Recherche Scientifique · FRUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contrary to acute pain, chronic pain does not serve as a warning signal and must be considered as a disease per se. This pathology presents a sensory and psychological dimension at the origin of affective and cognitive disorders. Being largely refractory to current pharmacotherapies, identification of endogenous systems involved in persistent and chronic pain is crucial. The amygdala is a key brain region linking pain sensation with negative emotions. Here, we show that activation of a specific intrinsic neuromodulatory system within the amygdala associated with type 4 metabotropic glutamate receptors (mGlu

Indexed as

AmygdalaAnimalsBasolateral Nuclear ComplexChronic PainFearMaleMiceMice, Inbred C57BLNeuronsNeurotransmitter AgentsPainReceptors, Metabotropic GlutamateSynaptic TransmissionThalamusmetabotropic glutamate receptor 4Neurotransmitter AgentsReceptors, Metabotropic Glutamate

Identifiers

PMID27994221
OpenAlexW2562256478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.